Dalgleish Scott 4/A
4/A · Oncology Institute, Inc. · Filed Mar 29, 2022
Insider Transaction Report
Form 4/AAmended
Dalgleish Scott
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-21+162,891→ 162,891 totalExercise: $7.09Exp: 2032-03-21→ Common stock (162,891 underlying)
Footnotes (1)
- [F1]The stock options vest as to 1/3rd of the options granted on the second anniversary of November 12, 2021 (the "Vesting Commencement Date"), with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.